New Delhi: The Russian ‘Sputnik V’ COVID-19 vaccine has arrived in India after Pharma major Dr Reddy’s Laboratories’ approval to conduct an adaptive phase 2/3 human clinical trial for the vaccine in India, reported news agency IANS.
A video that surfaced on the social media showed containers with logos of Dr Reddy’s and Sputnik V being unloaded from a small truck.
Russia’s National Research Centre for Epidemiology and Microbiology and the Russian Direct Investment Fund declared on Wednesday that the Sputnik V vaccine demonstrated 92 per cent efficacy.
The Lancet, world’s leading medical journal, on September 4, published a research paper on the results of Phase I and Phase II clinical trials of the vaccine. The trials showed no serious adverse events and effective immune response of those vaccinated, as per the news agency report.
Comments are closed.